Neuroinflammatory conditions

Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial

Study Overview The clinical trial investigated the use of hyaluronidase-facilitated subcutaneous immunoglobulin (Ig) 10% as a long-term maintenance therapy for

Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial Read Post »

Reply to the Letter “Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barre Syndrome of a Severe Refractory Case”

Clinical Presentation The clinical manifestation of acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) often overlaps with conditions such as Guillain-Barré Syndrome

Reply to the Letter “Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barre Syndrome of a Severe Refractory Case” Read Post »

Scroll to Top